Spinal Cord Stimulation Devices Market Size to Exceed $4.18 Billion by 2029 | Growth and Industry Trends
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Spinal Cord Stimulation Devices Market Grown from 2024 to 2025?
There has been significant progress in the market size for spinal cord stimulation devices in the previous years. The market, which is expected to leap from $2.74 billion in 2024 to $2.99 billion in 2025, will do so at a compound annual growth rate (CAGR) of 9.01%. Factors that contributed to this growth during the historical period include enhanced clinical results and patient satisfaction, heightened awareness of pain management alternatives, an increase in support for reimbursements, a surge in clinical research and regulatory approvals, and the development of pain management clinics and centers.
What Growth Rate Is Anticipated for the Spinal Cord Stimulation Devices Market in the Coming Years?
The market size for spinal cord stimulation devices is anticipated to experience robust growth in the coming years, with an expected value of $4.18 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 8.75%. The upward trajectory during the forecast period can be credited to factors such as growing instances of chronic pain conditions, a rising preference for non-opioid pain control methods, an expanding elderly population base, favorable reimbursement policies, increased use of wireless and rechargeable appliances, and heightened knowledge about neuromodulation therapies amongst medical professionals and patients. The forecast period will also witness significant trends such as improvements in minimally invasive techniques, advancements in wireless and rechargeable devices, progress in frequency stimulation, the adoption of closed-loop feedback mechanisms, the incorporation of wireless connectivity, development of advanced waveform selections, and the customization of pain management algorithms.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20964&type=smp
Who Are the Leading Companies in the Spinal Cord Stimulation Devices Market?
Major companies operating in the spinal cord stimulation devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Nevro Corp., Bluewind Medical, NeuroPace Inc., Vertos Medical Inc., SPR Therapeutics Inc., Saluda Medical Pty Ltd., Stimwave Technologies Inc., Nuvectra Inc., Soterix Medical Inc., Synapse Biomedical, ONWARD Medical NV, NeuroSigma Inc., Nalu Medical Inc., Neurostim Technologies, SpineX Inc., Aleva Neurotherapeutics SA, GTX Medical BV
What Are the Key Drivers of the Spinal Cord Stimulation Devices Market?
The escalation in chronic pain incidents is anticipated to propel the expansion of the spinal cord stimulation devices market. Chronic pain is a persistent discomfort that lasts for 12 weeks or more and originates from conditions such as arthritis, neuropathy, or lower back pain. The surge in these incidents is the result of several factors, such as aging population, lifestyle modifications, chronic health ailments, and injuries or trauma. Spinal cord stimulation (SCS) devices counter chronic pain by manipulating pain signals through electrical impulses, thus offering a respite from enduring conditions. For instance, Centers for Disease Control and Prevention, a US government agency, reported in November 2024 that in 2023, 24.3% of adults experienced chronic pain, with 8.5% suffering from high-impact chronic pain, making up 34.9% of those dealing with chronic pain. Consequently, the increasing frequency of chronic pain incidents is energizing the growth of the spinal cord stimulation devices market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=20964&type=smp
What Are the Key Market Segments in the Spinal Cord Stimulation Devices Industry?
The spinal cord stimulation devices market covered in this report is segmented –
1) By Type: Implantable Spinal Cord Stimulators, Non-Implantable Spinal Cord Stimulators
2) By Product Type: Rechargeable Devices, Non-Rechargeable Devices
3) By Application: Failed Back Surgery Syndrome, Complex Regional Pain Syndrome, Degenerative Disc Disease, Unsuccessful Disk Surgery, Other Applications
4) By End User: Hospitals, Ambulatory Surgical Centers, Neuro Clinics
Subsegments:
1) By Implantable Spinal Cord Stimulators: Rechargeable Spinal Cord Stimulators, Non-Rechargeable Spinal Cord Stimulators, Multi-Lead Implantable Spinal Cord Stimulators
2) By Non-Implantable Spinal Cord Stimulators: External Spinal Cord Stimulators, Wearable Spinal Cord Stimulators, Transcutaneous Spinal Cord Stimulators
What Are the Latest Trends in the Spinal Cord Stimulation Devices Market?
Top companies in the spinal cord stimulation devices industry are concentrating on creating innovative technologies like rechargeable spinal cord stimulation systems. They aim to improve patient results, extend the life span of devices, and present customized pain management solutions for chronic pain sufferers. Rechargeable spinal cord stimulation (SCS) systems are sophisticated devices that alleviate chronic pain by providing electrical shocks to the spinal cord. Notably, in December 2022, Abbott Laboratories, an American medical device manufacturer, was granted approval for its Eterna spinal cord stimulation (SCS) system by the US Food and Drug Administration (FDA). This revolutionary device presents a solution for managing chronic pain, using a compact design combined with leading-edge functions, enhancing the comfort and lessening the physical strain on patients. Its rechargeability ensures longevity, reducing the necessity for surgical replacements and adding convenience. The system comes with exact pain relief capabilities that can be personalized according to individual patient needs. The design of the system is simple yet innovative, facilitating minimally invasive implantation, which cuts down recovery time and enhances patient results overall.
Access The Full Report Here:
What Are the Key Regional Markets in the Spinal Cord Stimulation Devices Industry?
North America was the largest region in the spinal cord stimulation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spinal cord stimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20964
This Report Delivers Insight On:
1. How big is the spinal cord stimulation devices market, and how is it changing globally?
2. Who are the major companies in the spinal cord stimulation devices market, and how are they performing?
3. What are the key opportunities and risks in the spinal cord stimulation devices market right now?
4. Which products or customer segments are growing the most in the spinal cord stimulation devices market?
5. What factors are helping or slowing down the growth of the spinal cord stimulation devices market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
